[ad_1]
GW Pharmaceuticals, the manufacturer of Epidiolex and Sativex, performed a clinical trial in 2012 on CBD oil for pain due to spinal cord injury. The result was disappointing. The treatment arm of the study (55 subjects) and the placebo arm (59 subjects) showed essentially the same level of improvement in neuropathic pain.
A 2015 study on CBD extracts for infantile epilepsy has amazing results. The researchers reported in Epilepsy & Behavior that "relocation to Colorado had a significant effect on response rates." Drugs are not normally affected by postal code or time zone
]. ] on CBD oil and other forms of cannabis for the management of neurological disorders was more positive, finding "the strongest evidence for the treatment of spasticity and neuropathic pain in multiple sclerosis in plates. "
There are also warnings. Thorsten Rudroff, Ph.D., professor of health sciences and exercise at Colorado State University, told Neurology Advisor that further studies on the CBD were needed.
"While cannabis seems to be effective in treating the symptoms of MS such as pain and spasticity, there are so many unknowns. For example, we do not know much about interactions with other drugs. Furthermore, according to my own research, it appears that cannabis may further impair cognitive function in people with MS, especially among the elderly, "said Rudroff
. CBD oil has a good safety profile, but according to Food Safety CBD petroleum products have problems with labeling accuracy, product quality and contaminants.
CBD oil must reliably provide a quality product. Medical users may have allergies, chemical sensitivities and, in the case of cancer patients or people with autoimmune disorders, a weakened immune system. For these people, purity and dose matter.
In addition, there are drug interactions to consider. Medline lists nearly a dozen drugs that potentially interact with CBD, such as amitriptyline, ibuprofen and meloxicam, which are frequently used by people with health problems
be based on science, not on marketing. As David Cbadaret, MD notes in his book, Stoned: A Case of Physician for Medical Marijuana : "Medical marijuana becomes too prevalent, and the risks are too great, to let the patient fend for himself , and let the buyer beware. "
At the present time, however, CBD oil is very much a buyer beware of the world." And the current hype is not helping.
Source link
